How to use the speech recognition tool?

NCT01521793

RET IRD 02

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or
Retinitis Pigmentosa (Extension of Study RET IRD 01)

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2012-01-01
  • Closing Date: 2014-05-01

Criteria

More information

Children: Yes

Adults: Yes

Funder Type: private

HCP: Other investigators


Within ERN-EYE members

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: